A-Z

Cardiovascular Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 549 Agreements Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 5月 9, 2024
Biotechnology, Medical Devices, Health, Health Technology, Cardiology, Collaboration, Hyperlink, Confidentiality, A-Z, Directory, Intellectual property, Lease

Cardiovascular Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the cardiovascular deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Cardiovascular Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the cardiovascular deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of 549 cardiovascular deals from 2016 to 2024.
  • The report also includes numerous table and figures that illustrate the trends and activities in cardiovascular deal making since 2016.
  • Directory of deals by company A-Z, therapy focus and technology type
    Analyzing contract agreements allows due diligence of:
    What are the precise rights granted or optioned?

Worldwide Dermatology Deals Collection, 2016-2024: Gain Access to Benchmark Analysis, Financial Terms, Leading Deals, Active Dealmakers, and Contract Documents of 452 Dermatology Deals - ResearchAndMarkets.com

Retrieved on: 
水曜日, 5月 8, 2024
Health, Pharmaceutical, Hyperlink, Dermatology, Confidentiality, Record, A-Z, Directory, Intellectual property, Lease

Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the world's leading biopharma companies.

Key Points: 
  • Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the world's leading biopharma companies.
  • Fully revised and updated, the report provides details of 452 dermatology deals from 2016 to 2024.
  • Dermatology Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of dermatology trends and structure of deals entered into by leading biopharma companies worldwide.
  • Dermatology Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
金曜日, 5月 3, 2024
Biotechnology, Pharmaceutical, Health, Chapter Six, Directory, Chapter Three, Hyperlink, Chapter One, Chapter, Chapter Five, Orientation, Confidentiality, A-Z, Chapter Four, Intellectual property

Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of hematology deals from 2016 to 2024.
  • Chapter 3 covers the financial deal terms for deals signed in the hematology field with stage of development announced.
  • Chapter 5 provides a comprehensive and detailed review of hematology deals signed and announced since 2016 where a contract document is available.

Infectious Diseases Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 1,726 Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
月曜日, 4月 29, 2024
Infectious Diseases, Biotechnology, Pharmaceutical, Health, Chapter Six, Directory, Chapter Three, Infection, Hyperlink, Chapter One, Chapter, Chapter Five, Orientation, A-Z, Chapter Four, Pharmaceutical industry

Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the world's leading biopharma companies.

Key Points: 
  • Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the world's leading biopharma companies.
  • Fully revised and updated, the report provides details of 1726 infectious disease deals from 2019 to 2024.
  • Chapter 5 provides a comprehensive and detailed review of infectious diseases deals signed and announced since 2019 where a contract document is available.
  • Infectious Diseases Collaboration and Licensing Deals includes:
    In Infectious Diseases Collaboration and Licensing Deals, the available deals are listed by:

Oncology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 3685 Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
水曜日, 4月 24, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Other Health, Chapter Three, Hyperlink, Chapter One, Chapter Five, Orientation, Chapter Four, Chapter Six, A-Z, Directory, Chapter, Nursing

Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of 3685 oncology deals from 2019 to 2024.
  • Chapter 5 provides a comprehensive and detailed review of oncology deals signed and announced since 2019 where a contract document is available.
  • Oncology Collaboration and Licensing Deals includes:
    In Oncology Collaboration and Licensing Deals, the available deals are listed by:

Analysis of Joint Venture Deals in Pharmaceuticals and Biotechnology Between 2016-2024 - ResearchAndMarkets.com

Retrieved on: 
月曜日, 4月 1, 2024
Biotechnology, Pharmaceutical, Health, Chapter Three, Chapter Four, Chapter, Chapter One, A-Z, Orientation, Chapter Five, Chapter Six, Directory

The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.
  • Joint Venture Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter joint venture deals.
  • Fully revised and updated, the report provides details of joint venture deals from 2016 to 2024.
  • Joint Venture Deals in Pharmaceuticals and Biotechnology includes:
    In Joint Venture Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

Distribution Deal Trends in Diagnostics Report 2024 with Analysis of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
金曜日, 3月 29, 2024
Professional Services, Health, Other Professional Services, Legal, Other Health, Pharmaceutical, Biotechnology, Chapter Four, Chapter Three, Chapter Five, Orientation, Chapter, Chapter One, Directory, A-Z, Publishing

The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.
  • Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals.
  • Fully revised and updated, the report provides details of distribution deals from 2016 to 2024.
  • Distribution Deals in Diagnostics provides the reader with the following key benefits:
    Directory of deals by company A-Z, therapy focus and technology type
    Distribution Deals in Diagnostics includes:
    In Distribution Deals in Diagnostics, the available deals are listed by:

Global Biotechnology Licensing Agreements Analysis Report 2024 with Directory of Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
金曜日, 3月 29, 2024
Health, Biotechnology, Directory, Chapter Three, Chapter Four, Chapter, Chapter One, Confidentiality, A-Z, Orientation, Chapter Five, Chapter Six

Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals.

Key Points: 
  • Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals.
  • Fully revised and updated, the report provides details of licensing deals from 2019 to 2024.
  • The deal directory includes a comprehensive listing of all licensing deals announced since 2019.
  • Directory of deals by company A-Z, therapy focus and technology type
    Licensing Deals in Biotechnology includes:
    Analyzing contract agreements allows due diligence of:
    What are the rights granted or optioned?

Biotechnology Collaboration Agreements Analysis Report 2024: Global Coverage, Deal Financials, Contract Documents, Deal Trends, Leading Dealmakers, Comprehensive Deal Directory 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
水曜日, 3月 13, 2024
Biotechnology, Other Professional Services, Professional Services, Health, Directory, Chapter Three, Chapter Four, Chapter, Chapter One, Confidentiality, A-Z, Orientation, Chapter Five, Chapter Six, Lease

Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals.

Key Points: 
  • Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals.
  • Fully revised and updated, the report provides details of collaboration deals from 2019 to 2024.
  • The report provides access to collaboration deal payment terms as announced between the parties.
  • Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

Pharmaceuticals and Biotechnology Asset Purchase Deal Trends Analysis Report and Directory 2024: Benchmark Data for Deals Signed Since 2016 by the World's Leading Life Science Companies - ResearchAndMarkets.com

Retrieved on: 
水曜日, 3月 13, 2024
Biotechnology, Pharmaceutical, Health, Directory, Chapter Three, Chapter Four, Chapter, Chapter One, Confidentiality, A-Z, Orientation, Chapter Five, Chapter Six

Asset Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

Key Points: 
  • Asset Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.
  • The report provides access to asset purchase deal payment terms as announced between the parties.
  • The report focuses on four primary types of asset available for purchase, business assets, product assets, royalty assets, and technology assets.
  • The deal directory includes a comprehensive listing of all asset purchase deals announced since 2016.